Cost-Minimization Analysis of Metformin and Acarbose in Treatment of Type 2 Diabetes.

Gu, Shuyan; Tang, Zhiliu; Shi, Lizheng; Sawhney, Monika; Hu, Huimei; Dong, Hengjin

Gu, Shuyan; Tang, Zhiliu; Shi, Lizheng; Sawhney, Monika; Hu, Huimei; Dong, Hengjin.

Afiliação

Gu S; Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Tang Z; Health Economics and Outcome Research, Bristol-Myers Squibb, Shanghai, China.
Shi L; Department of Global Health Systems and Development, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
Sawhney M; College of Health Professions, Marshall University, Huntington, WV, USA.
Hu H; Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Dong H; Center for Health Policy Studies, School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Electronic address: donghj@zju.edu.cn.

Value Health Reg Issues ; 6: 84-88, 2015 May.

Article em En | MEDLINE | ID: mdl-29698199

Palavras-chave

acarbose; cost-minimization; metformin; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google